There is the CF review from the FDA that is due in the next couple of weeks, too. I think the stink is starting to dissipate from GILD. Expect a good little run to materialize. Mid 50's not out of the question.
GILD isn't up on vapor either. They will earn $4 in 2010! Put a 20 (below growth rate) multiple on that.